Joel Greenblatt's LGND Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 9,346 shares of Ligand Pharmaceuticals Incorporated (LGND) worth $1.77 M, representing 0.01% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in LGND, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2014, adding 496,561 shares. Largest reduction occurred in Q4 2014, reducing 548,287 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Ligand Pharmaceuticals Incorporated (LGND) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ligand Pharmaceuticals Incorporated (LGND) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -129 | Reduce 1.36% | 9,346 | $189.07 |
| Q3 2025 | +9,475 | New Buy | 9,475 | $177.14 |
| Q2 2025 | -6,912 | Sold Out | 0 | $0.00 |
| Q1 2025 | +6,912 | New Buy | 6,912 | $105.14 |
| Q1 2024 | -4,183 | Sold Out | 0 | $0.00 |
| Q4 2023 | -3,300 | Reduce 44.10% | 4,183 | $71.42 |
| Q3 2023 | -1,799 | Reduce 19.38% | 7,483 | $59.92 |
| Q2 2023 | +5,037 | Add 118.66% | 9,282 | $72.10 |
| Q1 2023 | +4,245 | New Buy | 4,245 | $73.56 |
| Q4 2022 | -4,543 | Sold Out | 0 | $0.00 |
| Q3 2022 | +1,400 | Add 44.54% | 4,543 | $86.07 |
| Q2 2022 | -1,437 | Reduce 31.38% | 3,143 | $89.09 |
| Q1 2022 | +1,122 | Add 32.45% | 4,580 | $112.45 |
| Q4 2021 | +1,051 | Add 43.66% | 3,458 | $154.42 |
| Q3 2021 | -155 | Reduce 6.05% | 2,407 | $139.18 |
| Q2 2021 | +526 | Add 25.83% | 2,562 | $131.15 |
| Q1 2021 | -1,679 | Reduce 45.20% | 2,036 | $152.26 |
| Q4 2020 | +3,715 | New Buy | 3,715 | $99.33 |
| Q1 2020 | -2,468 | Sold Out | 0 | $0.00 |
| Q4 2019 | +343 | Add 16.14% | 2,468 | $104.13 |
| Q3 2019 | -62,546 | Reduce 96.71% | 2,125 | $99.76 |
| Q2 2019 | +39,236 | Add 154.26% | 64,671 | $114.15 |
| Q1 2019 | +8,878 | Add 53.62% | 25,435 | $125.69 |
| Q4 2018 | -11,254 | Reduce 40.47% | 16,557 | $135.71 |
| Q3 2018 | +13,820 | Add 98.78% | 27,811 | $274.50 |
| Q2 2018 | -2,319 | Reduce 14.22% | 13,991 | $207.20 |
| Q1 2018 | -35,790 | Reduce 68.69% | 16,310 | $165.17 |
| Q4 2017 | +52,100 | New Buy | 52,100 | $136.93 |
| Q2 2017 | -117,749 | Sold Out | 0 | $0.00 |
| Q1 2017 | +83,784 | Add 246.68% | 117,749 | $105.84 |
| Q4 2016 | -4,266 | Reduce 11.16% | 33,965 | $101.60 |
| Q3 2016 | -33,639 | Reduce 46.81% | 38,231 | $102.06 |
| Q2 2016 | +50,048 | Add 229.35% | 71,870 | $119.27 |
| Q1 2016 | +21,822 | New Buy | 21,822 | $107.09 |
| Q1 2015 | -3,766 | Sold Out | 0 | $0.00 |
| Q4 2014 | -548,287 | Reduce 99.32% | 3,766 | $53.11 |
| Q3 2014 | +496,561 | Add 894.83% | 552,053 | $46.99 |
| Q2 2014 | +55,492 | New Buy | 55,492 | $62.30 |
| Q1 2014 | -13,803 | Sold Out | 0 | $0.00 |
| Q4 2013 | +7,667 | Add 124.95% | 13,803 | $52.60 |
| Q3 2013 | +6,136 | New Buy | 6,136 | $43.35 |
Joel Greenblatt's Ligand Pharmaceuticals Incorporated Investment FAQs
Joel Greenblatt first purchased Ligand Pharmaceuticals Incorporated (LGND) in Q3 2013, acquiring 6,136 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Ligand Pharmaceuticals Incorporated (LGND) for 41 quarters since Q3 2013.
Joel Greenblatt's largest addition to Ligand Pharmaceuticals Incorporated (LGND) was in Q3 2014, adding 552,053 shares worth $25.94 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 9,346 shares of Ligand Pharmaceuticals Incorporated (LGND), valued at approximately $1.77 M.
As of the Q4 2025 filing, Ligand Pharmaceuticals Incorporated (LGND) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Ligand Pharmaceuticals Incorporated (LGND) was 552,053 shares, as reported at the end of Q3 2014.